PND7 BUDGET IMPACT AND COST—EFFECTIVENESS OF SUGAMMADEX IN THE REVERSAL OF PATIENTS WITH NEUROMUSCULAR BLOCK

Autor: Sabater, FJ, Aguilera, L, Canet, J, Echevarria, M, Lora-Tamayo, JI, Poveda, JL, Sabaté, A, López-Belmonte, JL
Zdroj: In Value in Health 2009 12(7):A366-A366
Databáze: ScienceDirect